GE; Shengxiang

Patent Applications and Registrations

Patent applications and USPTO patent grants for GE; Shengxiang.The latest application filed is for "complex for intracellular delivery of molecules".

Company Profile

8.15.19

GE; Shengxiang - Xiamen Fujian
Ge; Shengxiang - Fujian CN
Ge; Shengxiang - Hangzhou N/A CN
GE; Shengxiang - Hangzhou City CN
Ge; Shengxiang - Xiamen City CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Complex For Intracellular Delivery Of Molecules App 20220265837 - GE; Shengxiang ; et al.	2022-08-25
Truncated rotavirus VP4 protein and application thereof Grant 11,339,194 - Ge , et al. May 24, 2	2022-05-24
Specific Antibody Against Human Anti-mullerian Hormone And Application Thereof App 20220146515 - XIONG; Junhui ; et al.	2022-05-12
Method For Full-range Detection Of C-reactive Protein And Corresponding Kit App 20210263029 - Chen; Zimin ; et al.	2021-08-26
A kit and method for quantitative detection of HBsAg App 20210164981 - WEN; Shunhua ; et al.	2021-06-03
Detection mechanism for polymerase chain reaction and polymerase chain reaction device Grant 10,864,521 - Qiu , et al. December 15, 2	2020-12-15
Truncated Rotavirus Vp4 Protein And Application Thereof App 20200308233 - Ge; Shengxiang ; et al.	2020-10-01
Truncated rotavirus VP4 protein and application thereof Grant 10,723,767 - Ge , et al.	2020-07-28
Reaction tube for nucleic acid amplification capable of controlling liquid circulation path Grant 10,487,301 - Ge , et al. Nov	2019-11-26
Rna Reverse Transcription Amplification Method App 20190316176 - ZHANG; Shiyin ; et al.	2019-10-17
Method for assessing risk of human cytomegalovirus active infection in body and related kit Grant 10,309,964 - Ge , et al.	2019-06-04
Reaction Tube For Nucleic Acid Amplification Capable Of Controlling Liquid Circulation Path App 20190055506 - GE; Shengxiang ; et al.	2019-02-21
Method And Kit For Diagnosis Of Active Tuberculosis App 20190025301 - GE; Shengxiang ; et al.	2019-01-24
Detection Mechanism for Polymerase Chain Reaction and Polymerase Chain Reaction Device App 20180326422 - Qiu; Xianbo ; et al.	2018-11-15
Truncated Rotavirus VP4 Protein And Application Thereof App 20180141978 - GE; Shengxiang ; et al.	2018-05-24
Anti-HBc quantitative detection method and uses thereof in monitoring and controlling disease progression of chronic hepatitis B patient and in predicting therapeutic effect Grant 9,952,217 - Yuan , et al. April 24, 2	2018-04-24
Method For Assessing Risk Of Human Cytomegalovirus Active Infection In Body And Related Kit App 20180031556 - GE; Shengxiang ; et al.	2018-02-01
Method for in-vitro preparation of double-layered virus-like particles of rotavirus Grant 9,862,933 - Ge , et al. January 9, 2	2018-01-09
Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof Grant 9,428,554 - Xia , et al. August 30, 2	2016-08-30
Method for In-Vitro Preparation of Double-Layered Virus-Like Particles of Rotavirus App 20150252334 - Ge; Shengxiang ; et al.	2015-09-10
Anti-hbc Quantitative Detection Method And Uses Thereof In Monitoring And Controlling Disease Progression Of Chronic Hepatitis B Patient And In Predicting Therapeutic Effect App 20150118674 - Yuan; Quan ; et al.	2015-04-30
Polypeptide fragments of the hepatitis E virus, the vaccine composition comprising said fragments and the diagnostic kits Grant 8,715,695 - Xia , et al. May 6, 2	2014-05-06
Polypeptide fragments of the hepatitis E virus, the vaccine composition comprising said fragments and the diagnostic kits Grant 8,524,868 - Xia , et al. September 3, 2	2013-09-03
Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof Grant 7,786,264 - Xia , et al. August 31, 2	2010-08-31
Polypeptide Fragments Of The Hepatitis E Virus, The Vaccine Composition Comprising Said Fragments And The Diagnostic Kits App 20100150962 - XIA; Ningshao ; et al.	2010-06-17
Polypeptide Fragments Of The Hepatitis E Virus, The Vaccine Composition Comprising Said Fragments And The Diagnostic Kits App 20100143410 - XIA; Ningshao ; et al.	2010-06-10
Monoclonal Antibody Against Hepatitis E Virus Or Its Fragment With Binding Activity And Use Thereof App 20100003281 - Xia; Ningshao ; et al.	2010-01-07
Polypeptide fragments of hepatitis E virus, the vaccine comprising said fragments and the diagnostic kits Grant 7,615,228 - Xia , et al. November 10, 2	2009-11-10
Monoclonal Antibodies Binding To Avian Influenza Virus Subtype H5 Haemagglutinin And Use Thereof App 20090068637 - Xia; Ningshao ; et al.	2009-03-12
Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof App 20060233822 - Xia; Ningshao ; et al.	2006-10-19
Polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kitsand the diagnostic kits App 20040052813 - Xia, Ningshao ; et al.	2004-03-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.